Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Vorsetuzumab mafodotin (ADC) (DHE01999)

Applications:Research Grade Biosimilar
Overview

Catalog No.

DHE01999

Description

Vorsetuzumab mafodotin is an ADC consisting of a CD70-directed antibody and McMMAF used for the study of renal cell carcinoma and non-Hodgkin's lymphoma.

Species reactivity

Human

Clonality

Monoclonal

Target

CD70

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SEC.

Purification

Purified by Ion Exchange Chromatography.

Applications

Research Grade Biosimilar

Form

Liquid

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

SGN-75

Clone ID

Vorsetuzumab mafodotin

Data Image
  • Bioactivity
    Detects CD70 in indirect ELISAs.
  • SEC-HPLC
    The purity of this product is >95% as determined by SEC-HPLC.
References
Datasheet

Document Download

Vorsetuzumab mafodotin (ADC).pdf

 

$ 2540
Product specifications
1 mg 2540 5 mg 6360

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Vorsetuzumab mafodotin (ADC) [DHE01999]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only